Dunhill Financial’s Pfizer PFE Stock Holding History

Dunhill Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.73M	Buy	113,506 +2,503	+2%	+$65.5K	0.56%	30
2026 Q1	$3.12M	Buy	111,003 +11,723	+12%	+$312K	0.73%	27
2025 Q4	$2.47M	Sell	99,280 -8,889	-8%	-$224K	0.6%	28
2025 Q3	$2.76M	Buy	108,169 +1,987	+2%	+$49K	0.72%	24
2025 Q2	$2.57M	Buy	106,182 +1,642	+2%	+$38.3K	0.75%	23
2025 Q1	$2.65M	Buy	104,540 +428	+0.4%	+$11.2K	1.2%	16
2024 Q4	$2.76M	Sell	104,112 -1,211	-1%	-$32.8K	1.28%	15
2024 Q3	$3.05M	Buy	105,323 +104,146	+8,848%	+$3.04M	1.57%	15
2024 Q2	$32.9K	Buy	1,177 +703	+148%	+$19.4K	0.02%	171
2024 Q1	$13.1K	Buy	474 +78	+20%	+$2.16K	0.01%	200
2023 Q4	$11.4K	Sell	396 -3,185	-89%	-$96.3K	0.01%	191
2023 Q3	$119K	Buy	3,581 +2	+0.1%	+$71	0.07%	70
2023 Q2	$131K	Buy	+3,579	New	+$139K	0.09%	71

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dunhill Financial's PFE Position: Q2 2026 in Review

Dunhill Financial increased its Pfizer (PFE) stake by 2.3% in Q2 2026, buying an estimated $65.5K and bringing the position to 113,506 shares worth $2.73M. The position accounts for 0.56% of the portfolio, ranked #30.

Dunhill Financial first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.12M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Dunhill Financial held 113,506 shares of Pfizer worth $2.73M as of Q2 2026.
Dunhill Financial bought 2,503 Pfizer shares in Q2 2026, an estimated $65.5K.
Pfizer made up 0.56% of Dunhill Financial's portfolio in Q2 2026, its #30 holding.
Dunhill Financial first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
Dunhill Financial's Pfizer position peaked at $3.12M in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.